Investors pour $10B into life sciences real estate this year

Rising rents have not been slowed by pandemic

National /
Jun.June 02, 2021 09:45 AM
Asking rents for labs or research buildings have been on the rise (iStock)

Asking rents for labs or research buildings have been on the rise (iStock)

The future of the office sector remains largely uncertain at this point post-pandemic, but there’s one segment that continues to see huge gains.

Investors have spent more than $10 billion on buying life sciences buildings this year, Bloomberg News reported, citing data from Real Capital Analytics. That’s about 4 percent of all global commercial real estate transactions through May, twice what was recorded at the same time last year.

And those numbers don’t even include new life-science developments, such as Boston’s massive Fenway Center, which broke ground in 2017.

Last year, life science building sales and refinancings totaled about $25 billion, a massive jump from $9 billion in 2019. In one huge deal, Blackstone received a $6.5 billion profit from refinancing BioMed Realty Trust, the largest life science offices REIT in the U.S.

Some of this can be attributed to the push to develop Covid-19 vaccines. But the sector was booming even before then: In some area where new projects have popped up — such as San Diego or Boston — asking rents for labs or research buildings have been on the rise. Rents in and around San Francisco have increased 90 percent in the past five years, while conventional office space has seen rents rise just 20 percent over the same period.

“The pandemic only amplified the demand growth, but it’s a trend we think will continue for years,” Nadeem Meghji, head of Blackstone’s Real Estate Americas group, told Bloomberg News.

Still, there’s some hesitancy surrounding the sector. Construction can cost 15 percent more than conventional offices and a risk of an oversupply remains possible as developers rush to break ground.

[Bloomberg News] — Sasha Jones





    Related Articles

    arrow_forward_ios
    SL Green CEO Marc Holliday (Getty, Sl Green)
    SL Green shareholders cry foul on CEO bonus
    SL Green shareholders cry foul on CEO bonus
    The New York Life Sciences and Biotechnology Center at First Avenue and 41st Street (NY Life Sciences)
    Life sciences leasing breaks annual record in five months
    Life sciences leasing breaks annual record in five months
    The commercial market was hit hard by the pandemic, and property tax revenue is expected to fall 5 percent. (iStock)
    Tax bills show how much Covid devalued NYC real estate
    Tax bills show how much Covid devalued NYC real estate
    Richard Segal of Seavest Investment Group, David Marx of Marx Development Group and 902 Quentin Road in Brooklyn (Photos via Seavest Investment Group, Marx Development Group and VRMNY)
    Westchester firm buys $54M Brooklyn medical building
    Westchester firm buys $54M Brooklyn medical building
    Real Estate EFTs See Investment Amid Pandemic Recovery
    Why investors are rushing into real estate ETFs
    Why investors are rushing into real estate ETFs
    Manhattan sublease surge shows signs of slowing
    Manhattan sublease scourge finally abates
    Manhattan sublease scourge finally abates
    Blooma founder Shayne Skaff (LinkedIn, iStock)
    CRE fintech startup Blooma nabs $15M in funding
    CRE fintech startup Blooma nabs $15M in funding
    Distressed real estate investors are digging through commercial mortgage-backed securities to seize, fix and flip troubled properties. (iStock)
    Distressed investors tap throwback strategy, target CMBS
    Distressed investors tap throwback strategy, target CMBS
    arrow_forward_ios

    The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

    Loading...